Cambria Investment Management, L.P. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 152 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cambria Investment Management, L.P. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$4,000
-66.7%
1,2400.0%0.00%
-50.0%
Q2 2015$12,000
+300.0%
1,240
+458.6%
0.00%
Q1 2015$3,0000.0%2220.0%0.00%
-100.0%
Q4 2014$3,0002220.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders